Loading company details...
Latest Form 4 (Nov 5, 2026): Eric W. Roberts (CHIEF BUSINESS OFFICER): Grant/Award of 180,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Eric W. Roberts, CHIEF BUSINESS OFFICER | Grant/Award | 180,000 | n/a |
| Oct 5, 2026 | Alan Glicklich | Grant/Award | 20,000 | n/a |
| Oct 5, 2026 | Evgeny Zaytsev | Grant/Award | 20,000 | n/a |
| Oct 5, 2026 | Frederic Guerard | Grant/Award | 20,000 | n/a |
| Oct 5, 2026 | Allan Shaw | Grant/Award | 20,000 | n/a |
| Oct 5, 2026 | Robert N. Wilson | Grant/Award | 20,000 | n/a |
| Sep 28, 2026 | Sudarshan Hebbar, Chief Medical Officer | Grant/Award | 180,000 | n/a |
| Sep 28, 2026 | Kenneth A. Stauderman, Chief Scientific Officer | Grant/Award | 180,000 | n/a |
| Sep 28, 2026 | Stephen Bardin, Chief Financial Officer | Grant/Award | 190,000 | n/a |
| Sep 28, 2026 | A. Rachel Leheny, CHIEF EXECUTIVE OFFICER | Grant/Award | 360,000 | n/a |